| George N Batty, MD | |
|
27 Industrial Ave Ste 101, Sanford, ME 04073-5846 | |
| (207) 459-1666 | |
| Not Available |
| Full Name | George N Batty |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 21 Years |
| Location | 27 Industrial Ave Ste 101, Sanford, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003020413 | NPI | - | NPPES |
| 300082470 | Medicaid | IN | |
| 200114712 | Medicaid | MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine Medical Center | Portland, ME | Hospital |
| Saint Mary's Hospital | Waterbury, CT | Hospital |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Indiana University Health Ball Memorial Hospital | Muncie, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Ball Memorial Physicians Inc | 9537072640 | 297 |
| Maine Medical Partners | 9335043967 | 789 |
| Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
Arab states must develop a plan to increase food security and create more jobs in order to meet Millennium Development Goal (MDG) targets by 2015, according to a report published Sunday by the United Nations Development Programme (UNDP), Reuters reports.
A federal grant will allow Johns Hopkins researchers to purchase a powerful $2 million computer that will speed up their efforts to find new ways to diagnose and treat brain disease, heart illnesses, cancer and other medical ailments.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
International Partnership for Microbicides (IPM) today announced that it has reached a farsighted agreement with Tibotec Pharmaceuticals Ltd, a subsidiary of Johnson & Johnson. The aim is to develop the promising compound TMC120 as a safe and effective microbicide to help protect women from infection with HIV. This agreement marks the first collaboration in the microbicide field between a major healthcare company and a public-private partnership such as IPM.
National drug safety experts, including representatives from the Center for Medicine in the Public Interest (CMPI) and the Critical Path Institute (CPI), will gather at the National Press Club and call for an improved approach to providing consumers with real time and individualized information about the risks and benefits of drugs on the market.
› Verified 9 days ago
| Entity Name | Indiana University Health Ball Memorial Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235455544 PECOS PAC ID: 9537072640 Enrollment ID: O20031110000505 |
News Archive
Arab states must develop a plan to increase food security and create more jobs in order to meet Millennium Development Goal (MDG) targets by 2015, according to a report published Sunday by the United Nations Development Programme (UNDP), Reuters reports.
A federal grant will allow Johns Hopkins researchers to purchase a powerful $2 million computer that will speed up their efforts to find new ways to diagnose and treat brain disease, heart illnesses, cancer and other medical ailments.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
International Partnership for Microbicides (IPM) today announced that it has reached a farsighted agreement with Tibotec Pharmaceuticals Ltd, a subsidiary of Johnson & Johnson. The aim is to develop the promising compound TMC120 as a safe and effective microbicide to help protect women from infection with HIV. This agreement marks the first collaboration in the microbicide field between a major healthcare company and a public-private partnership such as IPM.
National drug safety experts, including representatives from the Center for Medicine in the Public Interest (CMPI) and the Critical Path Institute (CPI), will gather at the National Press Club and call for an improved approach to providing consumers with real time and individualized information about the risks and benefits of drugs on the market.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George N Batty, MD 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-7000 | George N Batty, MD 27 Industrial Ave Ste 101, Sanford, ME 04073-5846 Ph: (207) 459-1666 |
News Archive
Arab states must develop a plan to increase food security and create more jobs in order to meet Millennium Development Goal (MDG) targets by 2015, according to a report published Sunday by the United Nations Development Programme (UNDP), Reuters reports.
A federal grant will allow Johns Hopkins researchers to purchase a powerful $2 million computer that will speed up their efforts to find new ways to diagnose and treat brain disease, heart illnesses, cancer and other medical ailments.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
International Partnership for Microbicides (IPM) today announced that it has reached a farsighted agreement with Tibotec Pharmaceuticals Ltd, a subsidiary of Johnson & Johnson. The aim is to develop the promising compound TMC120 as a safe and effective microbicide to help protect women from infection with HIV. This agreement marks the first collaboration in the microbicide field between a major healthcare company and a public-private partnership such as IPM.
National drug safety experts, including representatives from the Center for Medicine in the Public Interest (CMPI) and the Critical Path Institute (CPI), will gather at the National Press Club and call for an improved approach to providing consumers with real time and individualized information about the risks and benefits of drugs on the market.
› Verified 9 days ago
Anna Marie Scopellito-olsen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 25a June St Ste 111, Sanford, ME 04073 Phone: 207-490-7998 | |
Mr. Harendra N Patel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 27 June St, Sanford, ME 04073 Phone: 207-324-7126 Fax: 207-324-4308 | |
Shelly Ann Miller, Internal Medicine Medicare: Medicare Enrolled Practice Location: 25 June Street, Suite 111, Sanford, ME 04073 Phone: 207-490-7968 Fax: 207-490-7969 | |
Dr. Barbara P Mccall, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 June Street, Suite 111, Sanford, ME 04073 Phone: 207-324-5968 Fax: 207-490-1758 | |
Dr. Sara Jane Erickson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1474 Main St, Sanford, ME 04073 Phone: 207-608-8442 Fax: 207-608-8443 | |
Dr. Anuja Sharma, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 25a June St, Suite 111, Sanford, ME 04073 Phone: 207-324-5968 Fax: 207-490-1758 |